Clinical Trials
2,936 trialsRemoval of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
OCTANE
University Health Network, Toronto
OPAL
iOMEDICO AG
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
BIO-PROSA
Regina Elena Cancer Institute
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer
Hellenic Cooperative Oncology Group
NIGHT-SCAN
Assistance Publique - Hôpitaux de Paris
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer
St. Olavs Hospital
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Mayo Clinic
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehensive Cancer Center
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
National Institutes of Health Clinical Center (CC)
Study of Radiation Exposure and Bilateral Breast Cancer
Memorial Sloan Kettering Cancer Center
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Memorial Sloan Kettering Cancer Center
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
QT-RIBRATING
CMC Ambroise Paré
Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer
Anhui Provincial Cancer Hospital
MASTECTAMINE
University Hospital, Montpellier
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
Pfizer
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC
Pfizer
A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)
Pfizer
ROSIE
Pfizer
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement
Mayo Clinic
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
UNC Lineberger Comprehensive Cancer Center
Research on the Development and Validation of Personalized Exercise Prescriptions for Breast Cancer Patients Based on Large Language Models
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Genomic Services Research Program
National Institutes of Health Clinical Center (CC)
ROSE
Ipsen
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
Mayo Clinic
BRAVE
Université de Sherbrooke
CASCADE
AstraZeneca
CAROLEEN
Novartis
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
University of Southern California
IMPACT
Lumicell, Inc.
PAMBRACA
University of Modena and Reggio Emilia
BRCA Mutations in Latinas
National Institutes of Health Clinical Center (CC)
CDK and Body Composition Study
Montefiore Medical Center
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Memorial Sloan Kettering Cancer Center
Pangeia-2
AstraZeneca
PG2 BEAM-S
E-DA Hospital
NodeSMART
University Hospitals of Derby and Burton NHS Foundation Trust
ESME-MBC
UNICANCER
Oncoplastic Surgery Outcomes Database
Tufts Medical Center
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
Wake Forest University Health Sciences